JMI LABS IS NOW PART OF LEARN MORE

Initial quality control evaluations for susceptibility testing of dalbavancin (BI397), an investigational glycopeptide with potent Gram-positive activity. by Anderegg TR, Biedenbach DJ, Jones RN and The Quality Control Working Group published in J. Clin. Microbiol. 2003; 41 (6): 2795-2796

View publication